Follow Slashdot blog updates by subscribing to our blog RSS feed


Forgot your password?
Back for a limited time - Get 15% off sitewide on Slashdot Deals with coupon code "BLACKFRIDAY" (some exclusions apply)". ×

Submission + - Novartis denied cancer drug patent in landmark Indian case (

beltsbear writes: Following a reasonable view of drug patents, the Indian courts have decided that making small changes to an existing patented drug are not worthy of a new patent. This ruling makes way for low cost Indian cancer drugs that will save lives.
From the Article:
"Novartis lost a six-year legal battle after the court ruled that small changes and improvements to the drug Glivec did not amount to innovation deserving of a patent. The ruling opens the way for generic companies in India to manufacture and sell cheap copies of the drug in the developing world and has implications for HIV and other modern drugs too."

This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.

Novartis denied cancer drug patent in landmark Indian case

Comments Filter:

At the source of every error which is blamed on the computer you will find at least two human errors, including the error of blaming it on the computer.